The First Human-to-Human Heart Transplant, 1967

The 1967 operation depended on safer operative practice, vascular suturing, blood banking, antibiotics, mechanical ventilation, intensive postoperative observation, and especially cardiopulmonary bypass. It also followed the 1954 identical-twin kidney transplant, which demonstrated that a solid organ could function after transfer but did not solve rejection between genetically different people.

In 1960, Richard Lower and Norman Shumway at Stanford published an orthotopic canine method that closely anticipated the human operation. Their paper is evidence of a reproducible laboratory technique, not proof that clinical problems had been solved. In January 1964, James Hardy's team at the University of Mississippi placed a chimpanzee heart in a dying man; the xenograft could not support human circulation and the patient died shortly afterward. Barnard's priority is therefore specifically the first human-to-human transplant (Lower and Shumway; Hardy et al.).

Barnard had trained at the University of Minnesota and observed transplant work in the United States. At Cape Town he led an established open-heart programme and drew on surgeons, anaesthetists, physicians, pathologists, microbiologists, radiotherapy staff, nurses, technicians, and laboratory research. His December paper acknowledged this wider international and institutional foundation, even though publicity rapidly condensed the event into the story of a single daring surgeon (Barnard; Brink and Hassoulas).

1. 1960: Lower and Shumway publish “Studies on Orthotopic Homotransplantation of the Canine Heart.” Homotransplantation, now usually called allotransplantation, meant transfer between members of one species (Lower and Shumway).
2. 23 January 1964: Hardy's Mississippi team attempts a chimpanzee-to-human heart xenotransplant. It establishes an earlier human operation but not human-to-human priority or sustained circulation (Hardy et al.).
3. 2 December 1967: Denise Darvall, aged twenty-five, suffers catastrophic injuries in a road collision and is taken to Groote Schuur. Her father consents to donation after being told that her injuries are beyond treatment (Brink and Hassoulas; Süttő).
4. Night of 2-3 December: after ventilation is withdrawn, the contemporary anaesthetic chronology records circulatory arrest at 2:32 a.m.; Barnard's surgical account says electrical inactivity was observed for five minutes before removal. The disagreement in the records should not be silently harmonized (Barnard; Süttő).
5. 3 December 1967: Darvall's heart is transplanted into Louis Washkansky, a fifty-four-year-old man with advanced coronary disease and heart failure. The graft sustains circulation and Washkansky recovers consciousness (Barnard).
6. 21 December 1967: Washkansky dies after eighteen days. The provisional autopsy reports extensive bilateral pneumonia and no definite microscopic evidence of graft rejection (Thomson).
7. 2 January 1968: Barnard's second recipient, Philip Blaiberg, receives a heart at Groote Schuur, leaves hospital, and lives for nineteen months. His course provided stronger evidence that transplantation might offer more than postoperative survival (Brink and Hassoulas).
8. 1968: more than one hundred procedures are attempted internationally. In August, the Harvard committee publishes criteria for “irreversible coma”; the World Medical Association debates and adopts its Declaration of Sydney on death (Brink and Hassoulas; Harvard committee; MacDonald).
9. 1969-1970: poor survival produces an informal clinical retreat rather than one universal, simultaneous ban. A few programmes, notably Stanford's, continue systematic work on selection, rejection surveillance, and postoperative care (MacDonald; Jamieson, Stinson, and Shumway).
10. 1980 onward: the introduction of ciclosporin (then commonly written cyclosporine) into heart-transplant regimens improves control of rejection and helps wider programmes resume. It was one important change among better selection, biopsy, infection control, preservation, and team organization (Jamieson, Stinson, and Shumway; Ishaq and Guha).

The procedure was orthotopic: most of Washkansky's diseased heart was removed, while cuffs of atrial tissue were retained for attachment to the donor heart. A heart-lung machine maintained his circulation during the replacement. In an adjacent theatre, Darvall's heart was cooled and perfused before transfer. These were adaptations of experimental and open-heart techniques already circulating among surgical centres (Lower and Shumway; Barnard).

Postoperative observation was intensive: the team continuously monitored the electrocardiogram and circulation and repeatedly assessed renal function, electrolytes, temperature, and possible infection. They had no reliable routine biopsy method for distinguishing rejection from infection. The contemporary report looked for indirect signs such as falling electrocardiographic voltage, altered enzymes, and reduced cardiac output (Barnard).

Washkansky received azathioprine, high-dose corticosteroids, local cobalt irradiation of the heart, and actinomycin C when rejection was suspected. The report's elaborate cleaning and isolation measures show that infection was anticipated, not an unforeseen side issue. When lung infiltrates appeared, clinicians initially struggled to distinguish pneumonia from the then-used category “transplant lung.” The autopsy attributed death to pneumonia and described the donor heart as functioning until late in the course; a provisional report cannot, however, prove that no rejection occurred at any point (Barnard; Thomson).

Darvall's father authorized use of her heart and a kidney; the surviving sources describe next-of-kin permission, not Darvall's own recorded consent. A neurosurgeon judged her brain injury lethal and beyond treatment. That prognosis should not be restated as a documented examination meeting current neurological criteria for death: the original report does not record a full brain-stem examination, and no such clinical record has been located (Süttő).

Barnard's published account says ventilation ceased and the team waited for absent heart activity, breathing, and reflexes; later clinical literature has consequently described this retrospectively as donation after circulatory determination of death. A 2025 re-examination argues that conflicting timings and a later, subsequently retracted recollection by Marius Barnard leave open whether potassium was used to arrest the heart. That article advances a contested interpretation, not a settled finding. The secure conclusion is narrower: surviving accounts conflict, and claims that Darvall was declared dead under later standardized “brain-death” rules overstate the evidence (Page, Messer, and Large; Süttő).

The Harvard committee's August 1968 report responded to two problems: ventilators could maintain bodily functions in patients with devastating brain injury, and transplantation created demand for viable organs. It proposed criteria for irreversible unresponsiveness and recommended that transplant clinicians not determine the donor's death. The report was influential, but it was neither the first discussion of neurological death nor a global rule that instantly settled law and practice (Harvard committee; MacDonald).

The first donor and recipient were classified as white under apartheid, and the operation took place in a hospital system structured by racial segregation. The National Party government used Barnard's celebrity to advertise South African modernity, while anti-apartheid campaigners argued that transplant law, unequal medical access, and the state's coercive power could not be separated from the surgical achievement. Their claims were political interventions as well as evidence of contemporary opposition; they should not be treated as neutral clinical reports (Terretta).

Hamilton Naki, a Black laboratory technician at the University of Cape Town, became highly skilled in experimental animal surgery and helped train researchers despite apartheid's barriers to formal advancement. Obituaries published after his death in 2005 claimed that he removed Darvall's heart. The BMJ later corrected its obituary: available testimony places Naki in the experimental laboratory, not the human operating theatre. The correction does not diminish his work; it distinguishes genuine, structurally under-recognized laboratory labour from a compelling but unsupported legend (BMJ correction).

Barnard's international fame made the transplant appear to be an individual conquest. The clinical papers instead reveal dozens of roles and departments. Publicity accelerated imitation before many centres possessed comparable experience or follow-up systems, illustrating how a spectacular “first” can circulate faster than the infrastructure needed to make it reliable (Brink and Hassoulas; Terretta).

The worldwide surge of 1968 was followed by high mortality and contraction. This was not a simple interval in which “nothing happened.” At Stanford and a small number of other centres, teams refined recipient and donor selection, learned to diagnose rejection through endomyocardial biopsy, improved organ preservation and infection control, and treated transplantation as a continuing programme rather than an isolated operation. By 1978 Stanford reported an expected one-year survival of about 70 percent in its series of 150 recipients (Jamieson, Stinson, and Shumway).

Ciclosporin then made more selective long-term immunosuppression possible, but it did not act alone or eliminate rejection, infection, drug toxicity, donor scarcity, or unequal access. Heart transplantation became an established treatment for selected people with advanced heart failure through the combination of drugs, biopsy, intensive care, procurement networks, specialist nursing, registries, and long-term surveillance (Ishaq and Guha).

The most defensible reputation of the 1967 operation is therefore neither “instant cure” nor mere publicity stunt. It proved that a human donor heart could sustain another person's circulation, exposed how far postoperative medicine lagged behind surgical technique, and forced public argument about whose death, consent, labour, and resources made organ replacement possible.